ID: ALA3417712

Max Phase: Preclinical

Molecular Formula: C13H16ClNO2

Molecular Weight: 253.73

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  O=C(O)CN1CCCC1Cc1ccccc1Cl

Standard InChI:  InChI=1S/C13H16ClNO2/c14-12-6-2-1-4-10(12)8-11-5-3-7-15(11)9-13(16)17/h1-2,4,6,11H,3,5,7-9H2,(H,16,17)

Standard InChI Key:  PJDHKIBKWZGLMJ-UHFFFAOYSA-N

Associated Targets(non-human)

GABA transporter 1 233 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 253.73Molecular Weight (Monoisotopic): 253.0870AlogP: 2.43#Rotatable Bonds: 4
Polar Surface Area: 40.54Molecular Species: ZWITTERIONHBA: 2HBD: 1
#RO5 Violations: 0HBA (Lipinski): 3HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: 1.59CX Basic pKa: 9.76CX LogP: 0.02CX LogD: 0.02
Aromatic Rings: 1Heavy Atoms: 17QED Weighted: 0.90Np Likeness Score: -1.13

References

1. Jurik A, Zdrazil B, Holy M, Stockner T, Sitte HH, Ecker GF..  (2015)  A binding mode hypothesis of tiagabine confirms liothyronine effect on γ-aminobutyric acid transporter 1 (GAT1).,  58  (5): [PMID:25679268] [10.1021/jm5015428]

Source